BENTSUR RON (Chairman & CEO) purchased 0.1% of their position (4.50K shares) of NUVECTIS PHARMA, INC. on the open market
Open‑market purchase worth $20.9K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/26/2024ACC: 0001104659-24-131541
DirectorOfficer· Chairman & CEO
Since Feb 2022
+4.50K
Net shares
Net buyer
$20.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
4.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.50K
Price / share
$4.65
Trade value
$20.93K
% of position
0.1%
12/24/2024
3.27M→3.27M
Total
Net shares
+4.50K
Net value
$20.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/24/2024 | P · Purchase | +4.50K | $4.65 | $20.93K | 0.1% | 3.27M | 3.27M |
| Total | +4.50K | $20.93K | ||||||
Derivative Transactions0
No derivative transactions reported